NEO
Price
$13.89
Change
-$0.35 (-2.46%)
Updated
Jul 24 closing price
Capitalization
1.81B
2 days until earnings call
Intraday BUY SELL Signals
VCYT
Price
$56.61
Change
-$1.27 (-2.19%)
Updated
Jul 24 closing price
Capitalization
4.52B
4 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

NEO vs VCYT

NEO vs VCYT Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
NEO vs. VCYT commentary
Jul 26, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NEO is a Hold and VCYT is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 26, 2026
Stock price -- (NEO: $13.89 vs. VCYT: $56.61)
Brand notoriety: NEO and VCYT are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: NEO: 40% vs. VCYT: 32%
Market capitalization -- NEO: $1.81B vs. VCYT: $4.52B
NEO [@Medical Specialties] is valued at $1.81B. VCYT’s [@Medical Specialties] market capitalization is $4.52B. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $17.05B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

NEO’s FA Score shows that 0 FA rating(s) are green whileVCYT’s FA Score has 0 green FA rating(s).

  • NEO’s FA Score: 0 green, 5 red.
  • VCYT’s FA Score: 0 green, 5 red.
According to our system of comparison, VCYT is a better buy in the long-term than NEO.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

NEO’s TA Score shows that 4 TA indicator(s) are bullish while VCYT’s TA Score has 2 bullish TA indicator(s).

  • NEO’s TA Score: 4 bullish, 5 bearish.
  • VCYT’s TA Score: 2 bullish, 6 bearish.
According to our system of comparison, NEO is a better buy in the short-term than VCYT.

Price Growth

NEO (@Medical Specialties) experienced а -4.93% price change this week, while VCYT (@Medical Specialties) price change was -4.26% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was -1.55%. For the same industry, the average monthly price growth was +2.80%, and the average quarterly price growth was +1.12%.

Reported Earning Dates

NEO is expected to report earnings on Jul 28, 2026.

VCYT is expected to report earnings on Jul 30, 2026.

Industries' Descriptions

@Medical Specialties (-1.55% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
VCYT($4.52B) has a higher market cap than NEO($1.81B). VCYT YTD gains are higher at: 34.466 vs. NEO (18.112). VCYT has higher annual earnings (EBITDA): 112M vs. NEO (-32.95M). VCYT has more cash in the bank: 439M vs. NEO (146M). VCYT has less debt than NEO: VCYT (39.3M) vs NEO (409M). NEO has higher revenues than VCYT: NEO (746M) vs VCYT (542M).
NEOVCYTNEO / VCYT
Capitalization1.81B4.52B40%
EBITDA-32.95M112M-29%
Gain YTD18.11234.46653%
P/E RatioN/A52.46-
Revenue746M542M138%
Total Cash146M439M33%
Total Debt409M39.3M1,041%
FUNDAMENTALS RATINGS
NEO vs VCYT: Fundamental Ratings
NEO
VCYT
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
60
Fair valued
62
Fair valued
PROFIT vs RISK RATING
1..100
10077
SMR RATING
1..100
9581
PRICE GROWTH RATING
1..100
3636
P/E GROWTH RATING
1..100
10056
SEASONALITY SCORE
1..100
4n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

NEO's Valuation (60) in the Medical Or Nursing Services industry is in the same range as VCYT (62) in the Biotechnology industry. This means that NEO’s stock grew similarly to VCYT’s over the last 12 months.

VCYT's Profit vs Risk Rating (77) in the Biotechnology industry is in the same range as NEO (100) in the Medical Or Nursing Services industry. This means that VCYT’s stock grew similarly to NEO’s over the last 12 months.

VCYT's SMR Rating (81) in the Biotechnology industry is in the same range as NEO (95) in the Medical Or Nursing Services industry. This means that VCYT’s stock grew similarly to NEO’s over the last 12 months.

VCYT's Price Growth Rating (36) in the Biotechnology industry is in the same range as NEO (36) in the Medical Or Nursing Services industry. This means that VCYT’s stock grew similarly to NEO’s over the last 12 months.

VCYT's P/E Growth Rating (56) in the Biotechnology industry is somewhat better than the same rating for NEO (100) in the Medical Or Nursing Services industry. This means that VCYT’s stock grew somewhat faster than NEO’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
NEOVCYT
RSI
ODDS (%)
Bearish Trend 3 days ago
86%
Bearish Trend 3 days ago
65%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
75%
Bearish Trend 3 days ago
81%
Momentum
ODDS (%)
Bearish Trend 3 days ago
79%
Bearish Trend 3 days ago
81%
MACD
ODDS (%)
Bearish Trend 3 days ago
87%
Bearish Trend 3 days ago
73%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
81%
Bearish Trend 3 days ago
80%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
78%
Bullish Trend 3 days ago
81%
Advances
ODDS (%)
Bullish Trend 11 days ago
77%
Bullish Trend about 1 month ago
73%
Declines
ODDS (%)
Bearish Trend 7 days ago
81%
Bearish Trend 3 days ago
79%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
80%
Bearish Trend 3 days ago
80%
Aroon
ODDS (%)
Bullish Trend 3 days ago
87%
Bullish Trend 3 days ago
82%
View a ticker or compare two or three
Interact to see
Advertisement
NEO
Daily Signal:
Gain/Loss:
VCYT
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
SCHH24.860.52
+2.14%
Schwab US REIT ETF™
LGOV20.880.01
+0.05%
First Trust Long Duration Opp ETF
AIEQ49.16-0.03
-0.07%
Amplify AI Powered Equity ETF
MYY15.28-0.05
-0.33%
ProShares Short MidCap400
TDAX22.98-0.47
-2.00%
TDAQ Lift ETF

NEO and

Correlation & Price change

A.I.dvisor indicates that over the last year, NEO has been loosely correlated with NTRA. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if NEO jumps, then NTRA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NEO
1D Price
Change %
NEO100%
-2.46%
NTRA - NEO
46%
Loosely correlated
-1.02%
PSNL - NEO
44%
Loosely correlated
-3.60%
RVTY - NEO
43%
Loosely correlated
-2.39%
ADPT - NEO
42%
Loosely correlated
-0.18%
VCYT - NEO
41%
Loosely correlated
-2.19%
More